News | September 05, 2023
Cipla Medpro South Africa to acquire Actor Pharma
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Cipla has a robust governance model focused on sustainability
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore
Point-of-Care solution to facilitate clinicians in quick and effective decision making
Cipla and Ethris partner for the development of mRNA-based therapies
_256_384.png)
Leuprolide Acetate Injection Depot contains 22.5 mg of leuprolide acetate for 3- month administration given as a single dose injection.
_256_384.png)
Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to digitally transform operations
Depending on the type of cancer, it can be used as monotherapy or combination as a part of first line regimen, maintenance regimen or relapsed settings
Subscribe To Our Newsletter & Stay Updated
